Boundless Bio (BOLD) Liabilities and Shareholders Equity (2023 - 2026)
Boundless Bio (BOLD) posted Liabilities and Shareholders Equity of $73.74 million for Q2 2026, down 58.9% from $179.45 million a year earlier and down 47.7% from the prior quarter.
Powered by 
Analysis
Boundless Bio (BOLD) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Boundless Bio's Liabilities and Shareholders Equity came in at $157.06 million, down 23.9% from FY2024.
- In prior years, Boundless Bio's Liabilities and Shareholders Equity was $206.41 million in FY2024 (+58.9%) and $129.89 million in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2023.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last five quarters, with growth averaging 0.7% over the last seven quarters.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $140.97 million (Q1 2026), $157.06 million (Q4 2025) and $168.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Boundless Bio | 56.41 Mn | 56.41 Mn | - | 73.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.74 Mn |
| Mar 31, 2026 | 140.97 Mn |
| Dec 31, 2025 | 157.06 Mn |
| Sep 30, 2025 | 168.72 Mn |
| Jun 30, 2025 | 179.45 Mn |
| Mar 31, 2025 | 191.24 Mn |
| Dec 31, 2024 | 206.41 Mn |
| Sep 30, 2024 | 175.09 Mn |
| Jun 30, 2024 | 188.20 Mn |
| Mar 31, 2024 | 117.08 Mn |
| Dec 31, 2023 | 129.89 Mn |
API Access
Boundless Bio Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BOLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BOLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BOLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();